HKIMG
BSX icon

Hutchens & Kramer Investment Management Group’s Boston Scientific BSX Stock Holding History

Hutchens & Kramer Investment Management Group’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-2,187
Closed -$221K – 163
2025
Q1 		$221K Sell
2,187
-103
-4% -$10.4K 0.12% 144
2024
Q4 		$205K Sell
2,290
-194
-8% -$17.1K 0.11% 153
2024
Q3 		$209K Sell
2,484
-241
-9% -$19K 0.12% 149
2024
Q2 		$208K Buy
+2,725
New +$199K 0.12% 142

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Hutchens & Kramer Investment Management Group's BSX Position: Q2 2025 in Review

Hutchens & Kramer Investment Management Group sold out of Boston Scientific (BSX) in Q2 2025, closing a stake of 2,187 shares — an estimated $221K sold.

Hutchens & Kramer Investment Management Group first reported a position in BSX in Q2 2024 and held it in 4 quarters. The position peaked at $221K in Q1 2025. 1,687 funds tracked by Wall St. Rank hold BSX as of Q2 2025.

  • Hutchens & Kramer Investment Management Group reported no remaining Boston Scientific position as of Q2 2025 after selling out during the quarter.
  • Hutchens & Kramer Investment Management Group sold 2,187 Boston Scientific shares in Q2 2025, an estimated $221K.
  • Hutchens & Kramer Investment Management Group first reported a position in Boston Scientific in Q2 2024 and held it in 4 quarters.
  • Hutchens & Kramer Investment Management Group's Boston Scientific position peaked at $221K in Q1 2025.
  • 1,687 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2025.

Based on Hutchens & Kramer Investment Management Group's 13F filing for Q2 2025, filed 5 Aug 2025.